Assignee
CLAVIUS PHARMACEUTICALS LLC
US·3 granted patents·1 citations·filing 2018–2021
Technology mixC07D3
Top patents by PatentIndex Score
3 records- 0172US11124509B2Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatmentCLAVIUS PHARMACEUTICALS LLC·Filed 2018·Granted Sep 21, 2021·1 cites·17 claims
- 0262US11845745B2Tri-substituted imidazoles for the inhibition of TGF beta and methods of treatmentCLAVIUS PHARMACEUTICALS LLC·Filed 2021·Granted Dec 19, 2023·0 cites·17 claims
- 0343US12077548B2Substituted imidazoles for the inhibition of TGF-β and methods of treatmentCLAVIUS PHARMACEUTICALS LLC·Filed 2019·Granted Sep 3, 2024·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when CLAVIUS PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →